Press Release
Business

Arthroplasty Infections Treatment Market Projected to Witness a Double-Digit CAGR During 2025

Arthroplasty is a surgical procedure used to restore, reconstruction and replacement of the joints. Arthroplasty procedures demand is growing with high pace and it emerges as mainstream surgeries. Arthroplasty can be performed for the osteoarthritis, rheumatoid arthritis, frozen shoulder, congenital dislocation, misaligned joint, joint stiffness, and other joint problems. Hip and knee replacement surgeries are the most commonly performed Arthroplasty surgeries. There are some possible complications and chances of infection are associated with the Arthroplasty, as it is a surgical procedure. Some complications include bleeding, infection, blood clots and loosening of prosthetic parts. Around 1% of people get a postoperative infection after arthroplasty. Arthroplasty infections can occur in a wound and deep around the implant. Arthroplasty infections treatment includes antibiotic therapy and in complicated cases surgeries. Oral or intravenous antibiotics are generally prescribed for superficial arthroplasty infections treatment. surgical procedure such as debridement, staged surgery, and single-stage surgery can perform in deep infection.

The growing number of arthroplasty related infection cases drive the growth of the arthroplasty infections treatment market. Increasing number of hip and knee replacement surgeries favors the growth of the arthroplasty infections treatment market. Increasing awareness among the general population regarding surgical site infections expected to propel the growth of the arthroplasty infections treatment market. Growing healthcare expenditure and the aging population expected to boost up the growth of the arthroplasty infections treatment market. Increasing prevalence of osteoporosis and osteoarthritis expected to propel the growth of the arthroplasty infections treatment market. The growing number of road accidents and sports injuries expected to increase the number of arthroplasties and fuel the growth of the arthroplasty infections treatment market. Advancement in technology and treatment option expected to favors the growth of the arthroplasty infections treatment market. Increasing new antibacterial and antimicrobial drug approval flourish the growth of the arthroplasty infections treatment market.

Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/29962?source=atm

The global arthroplasty infections treatment market is segmented on basis of treatment type, infection type, distributional sales and region: Segmentation by Treatment Type Oral Antibiotic Therapy Intravenous Antibiotic Therapy Antibiotic Spacer Segmentation by Infection Type Hip Arthroplasty Infection Knee Arthroplasty Infection Shoulder Arthroplasty Infection Others Segmentation by Distributional Sales Institutional Sales Hospitals Ambulatory Surgical Centers Retail Sales Hospital Pharmacies Retail Pharmacies Online Pharmacies

Global arthroplasty infections treatment market expected to grow with a significant growth rate as increasing hip and knee arthroplasty surgeries. By treatment type, global arthroplasty infections treatment market is segmented into oral antibiotic therapy, intravenous antibiotic therapy, and antibiotic spacer. By application, global arthroplasty infections treatment market is segmented into hip arthroplasty infection, knee arthroplasty infection, shoulder arthroplasty infection and others. By distributional sales, global arthroplasty infections treatment market is segmented into institutional sales and retail sales.

North America expected to dominate the global arthroplasty infections treatment market as increasing number hip and knee replacement surgeries in the U.S. According to the American Academy of Orthopaedic Surgeons, by 2030 total hip replacement surgeries expected to reach 1.28 Mn procedure. Europe expected to contribute second-highest revenue share in global arthroplasty infections treatment market as high prevalence of osteoarthritis. Japan expected to contribute significant share in the global arthroplasty infections treatment as an increasingly aging population, growing need of surgeries and higher affordability rate. The Asia Pacific expected to grow with the highest growth rate in the arthroplasty infections treatment market. China and India expected to grow with a higher pace as an increasing number of Arthroplasty in countries and high patient pool. Middle East & Africa expected to grow with the lowest growth rate due to lack of awareness and poor medical facilities.

Request Report Methodology at https://www.persistencemarketresearch.com/methodology/29962?source=atm

Some of the players operating in the global arthroplasty infections treatment market are Exactech, Inc., implant cast GmbH, OsteoRemedies LLC, Ortho Development Corporation, Zimmer Biomet, Pfizer Inc., Merck & Co., Johnson & Johnson, Abbott Laboratories, Eli Lilly & Company, Allergen plc., Novartis AG, Bayer AG, GlaxoSmithKline plc., Sanofi SA and others.

The report covers exhaustive analysis on: Arthroplasty Infections Treatment Market Segments Arthroplasty Infections Treatment Market Dynamics Historical Actual Market Size, 2014 – 2018 Arthroplasty Infections Treatment Market Size & Forecast 2019 to 2029 Arthroplasty Infections Treatment Market Current Trends/Issues/Challenges Competition & Companies involved Arthroplasty Infections Treatment Market Drivers and Restraints

Regional Analysis: North America Latin America Europe Asia Pacific Middle East & Africa

Report Highlights: Shifting industry dynamics In-depth market segmentation Historical, current and projected industry size recent industry trends Key competition landscape Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards market performance

Request to view TOC at https://www.persistencemarketresearch.com/toc/29962?source=atm